SGP
SpyGlass Pharma, Inc.
34.97
+0.79 (+2.31%)
52w low 17.06
39.92 high
78.3% of range
Financial Analysis
| (USD) | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Cash & Equivalents | 15.85M | 16.27M | 96.36M | |
| Receivables | 122.91K | 423.00K | 431.00K | |
| Current Assets | 40.61M | 17.41M | 108.77M | |
| Net PP&E | 448.49K | 5.46M | 3.89M | |
| Total Assets | 41.15M | 23.32M | 115.87M | |
| Current Liabilities | 1.59M | 7.79M | 8.58M | |
| Total Debt | 0.00 | 3.90M | 1.58M | |
| Total Liabilities | 74.13M | 83.79M | 214.70M | |
| Retained Earnings | -35.70M | -64.86M | -104.73M | |
| Shareholders Equity | -32.99M | -60.47M | -98.84M | |
| Working Capital | 39.03M | 9.62M | 100.18M | |
| Shares Outstanding | 31.91M | 31.91M | 31.91M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--